Feedback / Questions
ceralifimod (ONO 4641) - Ono Pharma
Q2 2012 Results
(Merck Serono)
-
Aug 15, 2012 -
Anticipated decision on initiation of P3 trial for MS in 2013
Anticipated new P3 trial • Anticipated phase shift
•
Immunology • Multiple Sclerosis
http://www.larvolonline.com/tlg/ccdb/MerckSeronoQ2'12ResultsPresentationAug152012.pdf
Aug 15, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
(IR8)